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ORIGINAL ARTICLE 
Local Experience of Transcutaneous Bilirubinometry – 
An Accurate Alternative to Serum Sampling?  
Michelle-Marie Boffa, Mark Anthony Bailey, Helen Borg, Victor Grech
BACKGROUND   
Babies are frequently referred to the Paediatric Emergency 
Department from the Breastfeeding Clinic and Community Discharge 
Liaison Service with jaundice, as indicated by high transcutaneous 
bilirubin (TCB) readings measured using transcutaneous 
bilirubinometry.  Serum bilirubin (SeB) testing is then performed in 
the Emergency Department and the decision for admission for 
phototherapy is based upon on the SeB.  Strict correlation between 
these modes of bilirubin measurement would negate the need to 
verify TCB with SeB in cases where the bilirubin level is clearly above 
the cut–off value, thus reducing hospital waiting time, costs and time 
to starting treatment.     
OBJECTIVES  
To establish whether TCB is a reliable screening test for neonatal 
jaundice that may require phototherapy based on the relationship 
between TCB and SeB levels in patients in Malta.   
METHOD  
Neonates referred from the Breastfeeding Clinic to the Paediatric 
Emergency Department with raised TCB levels over five months 
(June-October 2017) were included.  Data was obtained from the 
Breastfeeding Clinic, local delivery suite and iSOFT Clinical 
Database, and interpreted using in-built data analysis tools and 
custom-made data analysis spreadsheets on Microsoft Excel®. 
RESULTS  
There was a significant difference between the two groups, with 
mean TCB being significantly greater than SeB (t=2.32, p=0.04), in 
fact TCB was greater than SeB in 18 out of 24 neonates.  However, 
TCB occasionally also under-read bilirubin levels. 
CONCLUSIONS 
These findings differ from results of similar studies conducted in 
other centres. Given the significant difference between TCB and SeB, 
it is recommended that, locally, TCB values continue to be cross-
checked with SeB levels in the Emergency Department prior to 
establishing the need for phototherapy in neonatal jaundice. 
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INTRODUCTION  
Neonatal jaundice is common, occurring in 
over 50% of term neonates and over 80% of 
pre-terms.1 Jaundice is the result of 
hyperbilirubinaemia, due to excess red blood 
cell breakdown or decreased excretion. It may 
be visually gauged, by looking for yellow 
discolouration at certain body sites such as the 
sclerae and the skin. However, this clinical 
method of detecting hyperbilirubinemia is 
subjective and should ideally be confirmed 
biochemically.2 
In many cases, neonatal jaundice is transient 
and resolves spontaneously. However, in 
others hyperbilirubinaemia may be a 
significant cause of morbidity and mortality, 
with neurological complications such as 
hearing loss, kernicterus leading to cerebral 
palsy, and a mortality of 7-10%.1-2  The aim of 
treatment is to reduce bilirubin levels before 
such complications occur.3 
Bilirubinometers used to consist of 2-
wavelength devices, i.e. 460nm and 520 nm, in 
order to generate a jaundice index.  This 
method, however, required that a baseline 
bilirubin measurement be known.3 Newer 
bilirubinometers, including those currently 
used locally (Philips BiliCheck®), utilise the 
entire visible spectrum (380 nm -760 nm) and 
have the advantage of not being affected by 
variables such as infant age, gestation or 
ethnicity, and do not require a baseline 
bilirubin level.3 
Locally, babies are frequently referred to the 
Paediatric Emergency Department from the 
Breastfeeding Clinic and the Community 
Discharge Liaison Service because of high 
transcutaneous bilirubinometry (TCB) 
readings.  Readings are obtained by applying 
the device to the sternum or forehead of the 
neonate.  Elevated bilirubin levels are then 
verified in the Emergency Department using 
serum bilirubin (SeB) levels and the need for 
admission for phototherapy based on the 
latter.   
This study was carried out to examine the 
association between TCB and SeB.   A close 
association would negate the need for 
unnecessary venupuncture and would 
decrease the time from first medical contact to 
starting phototherapy, in patients in whom 
TCB levels are clearly elevated above accepted 
cut-off levels.  Furthermore, it would also 
decrease hospital costs associated with SeB 
sampling and analysis. 
METHOD 
This study was conducted at Mater Dei 
Hospital, Malta, the country’s main hospital 
(928 in-patient and 86 day-care beds).4   It 
included all neonates referred from the local 
Breastfeeding Clinic to the Paediatric 
Emergency Department with neonatal 
jaundice as indicated by a raised TCB level, 
measured using Philips® BiliChek monitoring 
device, over a five month period (June-
October 2017).  Data from this cohort was 
obtained directly from the Breastfeeding 
Clinic, with information regarding gestational 
age obtained from the local delivery suite in 
patients in whom this had not been 
documented by the Breastfeeding Clinic.   
SeB was obtained from iSOFT Clinical 
Database for the remaining 24 neonates, the 
lab test used being the ‘total bilirubin level’ 
(BILT3 Cobas®).   
STATISTICAL ANALYSIS 
Data was subsequently interpreted using data 
analysis tools in Microsoft Excel and custom-
made spreadsheets with data analysis 
functions.   
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A contingency table was drawn up to 
determine the use of TCB as a screening test 
for SeB, based on whether or not 
phototherapy as predicted by TCB was actually 
required at respective SeB values, and data 
interpreted from this table to look at positive 
and negative predictive values of TCB.   
TCB results >350 mol L-1 were also analysed 
separately from TCB <350 mol L-1 due to the 
fact that values >350 mol L-1 encompassed all 
readings above 350 mol L-1and could not be 
translated as a simple numerical figure for 
interpretation.   Statistics were calculated for 
the 14 TCB values <350 mol L-1 and their 
respective SEB values, with a paired t-test to 
assess relationship.  Of the TCB values 
<350mol L-1 the differences between TCB and 
respective SeB were calculated and statistics 
for these differences obtained, looking at 
under- and over-reading by the device.   
The following were exclusion criteria for our 
study:  
• Babies referred from the Breastfeeding 
Clinic to the Paediatric Emergency 
Department for jaundice on dates outside 
the study period 
• Neonates born at <35 weeks gestational 
age 
• Measurements before one day of age 
(before first 24 hours) 
 
RESULTS 
During the study-period, we looked at 25 
neonates referred from the breastfeeding 
clinic in view of raised TCB levels, however, one 
was excluded from data interpretation in view 
of TCB level not having been documented 
prior to referral to Emergency Department.  
Results wherein TCB was indicated as >350 
mol L-1 were analysed separately. For those 
<350 mol L-1, summary statistics for the two 
groups are shown in table 1.  
Table 1 Summary Statistics for TCB and 
SeB values in patients with TCB <350 µmol L-1, 
showing 95% lower confidence intervals (LCI) 
and upper confidence intervals (UCI) 
There was a significant difference between the 
two groups in that mean TCB was significantly 
greater than SeB (t=2.32, p=0.04), as shown in 
table 2 which gives the values for the t-test 
employed in this study.  
Table 2 Paired t-test for TCB and SeB 
values in patients with TCB <350 µmol L-1 
Results       
LCI 
(95%) 
UCI 
(95%) 
Sensitivity  94.7% 71.9% 99.7% 
Specificity  40.0% 7.3% 83.0% 
Positive 
predictive value 85.7% 62.6% 96.2% 
Negative 
predictive value 66.7% 12.5% 98.2% 
Accuracy  83.3% 61.8% 94.5% 
Relative risk  2.6    
Odd's ratio   12.0     
  TC SeB 
Mean 306.2143 288.5214 
Variance 578.6429 1178.482 
Observations 14 14 
Pearson 
Correlation 0.572894  
Hypothesized 
Mean Difference 0  
Df 13  
t Stat 2.32469  
P(T<=t) one-tail 0.018463  
t Critical one-tail 1.770933  
P(T<=t) two-tail 0.036926  
t Critical two-tail 2.160369   
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However, TCB occasionally also under-read 
bilirubin levels, and the differences are 
summarised in table 3 which compares the 
extent at of under- and over-reading of TCB.  
 
Table 3 Extent of under- and over-reading 
for TCB 
  Under Over 
Mean -17.4 31.7 
Median -17.8 33.7 
Standard Deviation 10.4 19.2 
Min -29.6 2.4 
Max -4.6 67.7 
N 4 10 
Confidence interval 16.5 13.7 
 
Table 4 Further statistics for TCB and SeB 
values in patients with TCB <350 µmol L-1 
  TC Serum 
Mean 306.2 288.5 
Median 306.5 286.9 
Standard Deviation 24.1 34.3 
Min 274.0 230.3 
Max 340.0 350.1 
Confidence interval 13.9 19.8 
 
Table 5 Contingency table indicating 
whether or not phototherapy was required 
based on values for TCB and SeB according to 
age-appropriate charts 
  
SeB  
Yes 
SeB 
No 
TCB 
Yes 18 3 
TCB 
No 1 2 
In fact, considering all neonates investigated, 
TCB levels were definitely greater than SeB in 
18 cases, however, in two cases where both 
TCB and SeB were >350 we were unable to 
determine which was actually higher.  In four 
cases TCB values were lower than SeB.  Note 
that in stating that TCB over- or under-read 
results, we assume that SeB is the gold-
standard method for analysing bilirubin levels.   
Further statistics for TCB and SeB values <350 
mol L-1 are seen in table 4, and the 
contingency table used to work out summary 
statistics is seen in table 5.   
TCB, as a screening test for the need for 
phototherapy in the setting of neonatal 
jaundice, while sensitive (sensitivity=94.7%) 
was poorly specific (specificity=40.0%).  In fact 
despite a positive predictive value of 85.7%, 
this method of gauging bilirubin levels has a 
negative predictive value of only 66.7%. 
DISCUSSION 
Contrary to results from similar studies 
conducted in other centres, there was a 
significant difference between the two groups 
in this study in that mean TCB was significantly 
greater than SeB.  Of note is a study performed 
by the Medical University of South Carolina in 
the USA, published in 2015.2  Here, the same 
bilirubinometer make was identical to that 
used in this study.   Srinivas et al. report that 
given the good correlation between TCB and 
SEB in their study, TCB could reliably be used 
as a stand-alone screening test for neonatal 
jaundice.    
The accuracy of TCB as a screening test for SeB 
was validated in many in-patient studies, with 
a correlation between BiliCheck® and high 
pressure liquid chromatography of 0.89 in one 
large, multicentre, hospital-based study. [3]  
Wickremasinghe et al (2011) noted a 
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decreased sensitivity and specificity of TCB in 
relation to SeB in an out-patient setting, with a 
tendency towards over-reading, and this was 
attributed to an increase in the incidence of 
hyperbilirubinaemia following hospital 
discharge, decreased moisture of neonatal 
skin and pigmentary differences.5 This 
tendency of TCB to over-read SeB is similar to 
that seen in this study.  Furthermore, Maisels 
et al., (2011) noted an increase in false 
negatives picked up by TCB with increasing 
TCB levels.6 Other out-patient based studies 
have shown a good correlation between TCB 
and SeB.7 
This study shows that TCB is not a reliable 
screening test for SeB.  Although our study 
showed a statistical difference between TCB 
and SeB (t=2.32, p=0.04), the limitations of our 
study include the following:  
a. Since TCB measurement was 
unwitnessed, the method of device use 
might have been suboptimal in some 
instances 
b. This study relied on TCB results collected 
by third-parties, however, although to our 
knowledge the majority of TCB levels of 
babies referred to the Paediatric 
Emergency Department in view of 
neonatal jaundice was documented, 
there might have been instances were no 
such record was kept, and the extent of 
under-documentation might have varied 
from individual to individual, with some 
midwives documenting results much 
more than others.  This should not have 
been an issue if there were no differences 
in TCB measurement technique by 
different midwives and if each midwife 
had the same threshold for TCB 
measurement with a bilirubinometer. 
c. Our data pool was small and the 
population size might have negatively 
affected reliability of results. 
d. The results obtained are relevant for the 
bilirubinometer used in our study. These 
may or may not be able be applicable to 
other bilirubinometers 
e. The following assumptions were made in 
our study, and these too might have 
affected results:  
• Transcutaenous bilirubinometry 
accuracy is independent of other 
variables including race,  gestational 
age, post-natal age, general health 
and nutrition status 
• Values on transcutaneous 
bilirubinometry are independent of 
site of measurement 
• The transcutaneous bilirubinometer 
was adequately calibrated and 
functioning well 
• Proper technique was used in 
obtaining transcutaneous bilirubin 
readings 
• Transcutaneous and serum bilirubin 
readings were done in close 
chronological proximity, i.e. the time 
lag between transcutaneous 
bilirubinometer and serum sampling 
was not significant enough to affect 
results 
• Serum samples were kept in similar 
conditions until analysed in the 
laboratory, including avoiding 
exposure to sunlight 
• The serum test done locally is reliable 
and provides a true value for serum 
bilirubin 
CONCLUSION  
Given the significant difference between TCB 
and SeB in our study, it is recommended that, 
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locally, baseline SeB levels continue to be 
checked prior to deciding on the need for 
phototherapy in neonatal jaundice unless a 
larger study concludes otherwise. It would be 
worth repeating this study at a later date using 
a larger cohort of patients, to conclude 
whether the results seen in our study were 
truly reliable, or whether they were seen by 
chance given the confounding factors of our 
study.  
SUMMARY 
The facts:  
1. In Malta, patients are routinely referred 
from the breastfeeding clinic in view of 
elevated TCB 
2. TCB gives a quick indication of SEB 
3. TCB and SEB values are well-comparable 
according to previous studies 
4. Using TCB values alone decreases on 
hospital waiting time and decreases time 
to start of treatment in 
hyperbilirubinaemia 
What’s new? 
1. TCB does not appear to be a sensitive 
enough indicator of SEB in our local 
cohort 
2. TCB over- and sometimes under-
estimates SEB  
3. TCB results as indicated from 
breastfeeding clinic referrals should 
continue to be verified with SEB in our 
local cohort to decide on treatment, 
unless a larger study proves otherwise 
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